Pamela Tranter

Head Translational Research Group, UCL Translational Research Office • UCL

Pamela joined UCL Translational Research Office (TRO) in 2014 and has been leading the Translational Research group since 2016.    The TRO collaborates with academics, industry partners and external funding bodies, to facilitate the translation of UCL’s emerging research into therapies and medical products.   Pamela is the project manager for substantial late pre-clinical/early clinical advanced therapy projects, with a particular emphasis on CAR T cells and  Rare diseases. The TRO has supported more than 100 active projects with a value of greater than £150 Million. 

 Pamela is leading a key initiative to develop Therapeutic Innovation Networks (TINs) for all therapeutic modalities across UCL, which is supported by a WT Translational Partnership Award.  

 Prior to joining UCL, Pamela gained extensive experience of drug discovery in the pharmaceutical industry at Novartis/Ciba-Geigy where she led small molecule and biologics projects for respiratory and thrombosis indications.  


Also speaking

Angela Justice

Chief People Officer • TCR2 Therapeutics

Jens Hasskarl

Chief Medical Officer • Tigen Pharma

Amandine Breton

Director of MSAT & Analytical Sciences  • Orchard Therapeutics

Event Info


Spotlight Roundtables

Take a look at the sample attendee list for Advanced Therapies Europe here.

Pub & Pints RSVP

Let us know you’re planning on attending.